 |
1-(4-(N-glycylamido)phenyl)-3-trifluoromethyl-5-(phenanthren-2-yl)-pyrazole-hydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | Tularaemia |
| EU Market Approval | EU |
| EU Designation Date | 2015-04-24 00:00:00 |
| Sponsor | Arno Therapeutics UK, Limited |
| |
1-(4-(N-glycylamido)phenyl)-3-trifluoromethyl-5-(phenanthren-2-yl)-pyrazole-hydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | Tularaemia |
| EU Market Approval | EU |
| EU Designation Date | 2015-04-24 00:00:00 |
| Sponsor | Arno Therapeutics UK, Limited |